J&J Unit Cuts Deal To End Cancer Drug Trade Secret Fight

By Dorothy Atkins · May 1, 2024, 5:40 PM EDT

A New Jersey federal judge has signed off on a consent judgment that permanently bars Chinese drugmaker Jiangsu Hengrui Pharmaceuticals Co. from misappropriating Johnson and Johnson's pharmaceutical subsidiary Janssen's trade secrets...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

JANSSEN PRODUCTS, L.P. et al v. EVENUS PHARMACEUTICALS LABORATORIES INC. et al

Case Number

1:22-cv-02499

Court

New Jersey

Nature of Suit

Defend Trade Secrets Act (of 2016)

Date Filed

April 28, 2022